Introduction: Minimal disease determination might serve for risk stratification, response evaluation and follow-up monitoring in childhood Non-Hodgkin lymphomas. Besides helping to judge minimal residual (MRD) during therapy, detection of disseminated (MDD) at diagnosis may be prognostic value itself. However, different subtypes, high cure rates, low patient numbers, limited initial tumour mate...